Podcast by The Motley Fool
Source
Johnson & Johnson raises full-year guidance after delivering 3rd-quarter results.
(0:22) Jason Moser discusses: – Highlights from JNJ’s medical device and consumer health divisions – The spinoff of consumer health coming in late 2023 – How investors can find dividend-payers to add to their portfolio
Relevant links to today’s episode: Dividend Aristocrats – https://www.fool.com/investing/stock-market/types-of-stocks/dividend-stocks/dividend-aristocrats/
Dividend Kings – https://www.fool.com/investing/stock-market/types-of-stocks/dividend-stocks/dividend-kings/
(13:20) Robert Brokamp talks David Blanchett, head of retirement research at PGIM, about the 4% rule and a common misconception about retirement spending.
Stocks mentioned: JNJ
Host: Chris Hill Guests: Jason Moser, Robert Brokamp, David Blanchett Producer: Ricky Mulvey Engineers: Dan Boyd, Rick Engdahl